What’s at stake in Amgen’s showdown with the FDA?

<figure><div><img src="https://imgproxy.divecdn.com/2N5bXpOLB1vtfzu44NRZGlCxFnLJtDDNIpvxoV2ZTGo/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDkxMDYwMjkxLmpwZw==.webp"/></div></figure><p>The agency accused Amgen of manipulating data for its fast-growing drug Tavneos and wants it pulled from the market, but the large pharma is digging its heels in.</p>

Meagan Parrish · 2026-05-05

What’s at stake in Amgen’s showdown with the FDA?

The agency accused Amgen of manipulating data for its fast-growing drug Tavneos and wants it pulled from the market, but the large pharma is digging its heels in.

Source: PharmaVoice